the ilera team

board of directors

Mr. Imasogie is the Co-Founder and Senior Managing Partner of PIPV Capital with over 30 years of experience in the fields of law, finance and business management, healthcare and the pharmaceutical industry. Prior to co-founding PIPV Capital, Osagie conceptualized and established GlaxoSmithKline Ventures in which he led his team in investing GSK R&D non-progressed assets into various companies and/or as the basis of starting new companies. Prior to this role within GSK, Osagie was a Vice President for Product Development Strategy at SmithKline Beecham. Prior to this role at SmithKline, he was the Founding Senior Vice President for Business Development and General Counsel at Endo Pharmaceuticals. He also previously served as a DuPont Merck Vice President for International Sales and Marketing and General Counsel to DuPont Merck’s International, Manufacturing and Generic Drug Divisions. Osagie has been a serial entrepreneur and has been founder and former CEO and/or Chairman of multiple life sciences companies, including Iroko Pharmaceuticals, iCeutica, Churchill Pharmaceuticals, Ception Therapeutics and Trigenesis Therapeutics. Osagie is also active in charitable and community pursuits and serves as a member of the Board of the Philadelphia Orchestra and the Philadelphia Museum of Art. Osagie is an Adjunct Professor at the University of Pennsylvania Law School and also serves on the Law School’s Board of Overseers. In addition, he is a member of the Board of Trustees of the University of Pennsylvania and serves as the Chairman of the Budget & Finance Committee in addition to being a member of the Executive Committee. Osagie is a member of the New York State Bar.

Osagie Imasogie

Ms. Gray has over 26 years of experience in finance, marketing, business development and operations primarily within the pharmaceutical industry. Lisa is the Co-Founder and Managing Partner of PIPV Capital, a Private Equity firm focused on building companies in life sciences, where she manages the financial aspects of the firm, generates and leads investments, manages investor communications, and acts as CEO, Board Member and/or plays various management roles, as necessary. Prior to founding PIPV Capital, Lisa worked with SmithKline, Beecham Pharmaceuticals, GlaxoSmithKline Pharmaceuticals, and Coopers and Lybrand. Ms. Gray is a Certified Public Accountant (CPA) and Certified Valuation Analyst (CVA). She holds a Bachelor’s of Science in Accountancy from Villanova University, an MBA in Finance and a Postgraduate Degree in Marketing Management. In addition, Lisa is active in various community efforts including YESUCAN, which is focused on improving lives of people with disabilities, The American Red Cross, The Villanova School of Business, and various youth programs.

Lisa Gray

Greg Rochlin is a serial entrepreneur, healthcare advocate and philanthropist. After graduating from the University of Maryland in 1987, Greg founded National Thermal Industries, a residential home improvement company, which he later sold to his business partner. From there, he moved into metals trading and recycling at Wise Recycling, which was the largest independent aluminum trading company in the world when he joined in 1992. Greg became the COO and eventually purchased the scrap division of the company, which was re-branded as Terrapin Recycling. Over the course of two decades, the company grew from processing 200,000 pounds of non-ferrous metal per month to more than ten million pounds per month, and diversified to include lucrative landfill, waste, and trucking services. Greg also founded Specialized Metal Solutions, an important supplier to the food container industry and metals trading firm, in 2006; he serves as CEO of the company. He is active in other industries as well – Greg is the CEO and co-owner of upscale Maryland wine and spirits chains and three real estate companies. Greg has campaigned and volunteered tirelessly for healthcare causes throughout his life. A long-time Sinai Hospital of Baltimore board member and current chair, Greg was the last chair of the LifeBridge Health Planning Committee, which oversees the planning and budgeting for future projects at Sinai, Northwest and Carroll Hospital. He has also served on the board of Snyder Center for Aphasia Life Enhancement (SCALE), where he was instrumental in guiding the organization’s merger with the League of People with Disabilities of Maryland. Greg has been the CEO of Ilera healthcare since its founding in 2016. Providing medical marijuana to patients gives him the opportunity to unite his business development acumen with his lifelong passion for compassion. His personal and professional experiences make him highly qualified to lead Ilera Healthcare.

Gregory Rochlin

Zoltan has over 24 years of experience in the fields of law and business primarily within the pharmaceutical industry. Zoltan is Co-Founder and Managing Partner of PIPV Capital, a Private Equity firm focused on life sciences. Zoltan was Head of GlaxoSmithKline Ventures’ “Pure IP” transactions group and was Senior Patent Counsel for GlaxoSmithKline and previously was an attorney focused on intellectual property litigation and IP transactional work with White & Case, a preeminent global law firm based in NYC and Hopgood, Calimafde, Kalil & Judlowe (now Morgan Lewis), an intellectual property litigation boutique firm. Zoltan has a BS in Biology from Fordham University and a JD from Boston University School of Law. He is a member of the New York State and Commonwealth of Massachusetts Bars. Zoltan is admitted to practice before the U.S. Patent and Trademark Office, the U.S. District Court for the Southern District of New York and the U.S. Court of Appeals for the Federal Circuit.

Zoltan Kerekes

Mr. Norin, CEO of The Agora Companies, began his career in public accounting 30 years ago. As The Agora Companies was one of his first clients, he has been very involved in its success since the beginning of his career, and has watched Agora grow from revenues of less than $10 million to become a company that grosses over $1 billion annually. Mr. Norin is responsible for the day-to-day management of the company’s U.S. operations, and has helped lead Agora’s expansion efforts into England, France, Germany, Australia, South Africa, Brazil, as well as others. Under his leadership, Agora began their use of the internet as a tool for daily communications with newsletter subscribers as well as a sales vehicle. Agora now generates the majority of its revenue through e-commerce sales.

Myles Norin

Mr. Geers is a Partner at Good Harbor Partners, LLC, an education advisory firm with deep expertise in educational technology, publishing, and digital media. Before joining Good Harbor Partners, Mr. Geers served as the Senior Vice President Corporate Development and Mergers and Acquisitions at Cengage Learning, one of the leading global education publishing companies. Mr. Geers also led the M&A and corporate development team at Thomson Reuters Healthcare and Science division. Prior to this, Mr. Geers was a VP for SAP AG where he served in a number of different corporate functions. Mr. Geers has been involved with startups and emerging companies as an investor, co-founder, and advisor. Geers is a licensed attorney in Germany and the State of New York and began his career as an associate in the Business and Finance section of Morgan, Lewis & Bockius LLP, a leading US law firm.

Torsten Geers

Shane A. Johnson

Outside Director

advisory board

Calvin B. Johnson M.D., M.P.H.

Stephanie Zarus

Michael N. Liebman, Ph.D.

Vince J. Kalish, Ph.D.

Brian Gimlett

management team

Gregory Rochlin

Oludare Odumosu

Chief Scientific Officer/EVP Pharmaceutical Division

Tom Borger

Andy Sack

Director of Cultivation

Amanda Fries

Director of Supply Chain and Logistics

Thanks for joining! Please check your email to confirm your subscription.

Oops! Something went wrong while submitting the form.